<?xml version="1.0" encoding="UTF-8"?>

<PlanDefinition xmlns="http://hl7.org/fhir">
  <id value="TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan"/>
  <meta>
    <profile value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: PlanDefinition TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan</b></p><a name="TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan"> </a><a name="hcTherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan"> </a><a name="TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan-en-US"> </a><p><b>url</b>: <a href="PlanDefinition-TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan.html">PlanDefinition Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients</a></p><p><b>version</b>: 7.0</p><p><b>name</b>: Therapeutic_Anticoagulation_No_Renal_Function_Impairment</p><p><b>title</b>: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <a href="EvidenceVariable-PopHospitalisedNonICUCOVID19PatientsWITHHighRisk.html">Population: Hospitalised COVID-19 patients without the need for intensive care therapy considered high-risk for developing venous thrombosis</a></p><p><b>date</b>: 2022-02</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered.</p>
</div><blockquote><p><b>goal</b></p><blockquote><p><b>id</b></p>aPTT-goal</blockquote><p><b>category</b>: <span title="Codes:{http://snomed.info/sct 410394004}">Lab findings surveillance (regime/therapy)</span></p><p><b>description</b>: <span title="Codes:">aPTT value should be &gt; 50 sec.</span></p><h3>Targets</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Measure</b></td><td><b>Detail[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://loinc.org 3173-2}">aPTT in Blood by Coagulation assay</span></td><td>50.0000001-? sec</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>goalId</b>: aPTT-goal</p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationUFH.html">Therapeutic Anticoagulation Treatment UFH</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin1xd.html">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin2xd.html">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHDalteparinTable.html">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHNadroparin.html">Therapeutic Anticoagulation Treatment with Nadroparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin1xd.html">Therapeutic Anticoagulation Treatment with Enoxaparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin2xd.html">Therapeutic Anticoagulation Treatment with Enoxaparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHCertoparin.html">Therapeutic Anticoagulation Treatment with Certoparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationFondaparinux.html">Therapeutic Anticoagulation Treatment with Fondaparinux</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>goalId</b>: aPTT-goal</p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationWArgatra.html">Therapeutic Anticoagulation Treatment with Argatroban</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationNMHTinzaparin.html">Therapeutic Anticoagulation Treatment with Tinzaparin</a></p></blockquote></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel">
    <valueCode value="structured"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf">
    <valueCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation"/>
  </extension>
  <extension url="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method">
    <extension url="method">
      <valueCodeableConcept>
        <coding>
          <system value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method"/>
          <code value="at-least"/>
        </coding>
      </valueCodeableConcept>
    </extension>
    <extension url="threshold">
      <valuePositiveInt value="1"/>
    </extension>
  </extension>
  <url value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/therapeutic-anticoagulation"/>
  <version value="7.0"/>
  <name value="Therapeutic_Anticoagulation_No_Renal_Function_Impairment"/>
  <title value="Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
      <code value="eca-rule"/>
    </coding>
  </type>
  <status value="active"/>
  <experimental value="true"/>
  <subjectCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/population/hospitalised-non-icu-covid19-patients-high-risk"/>
  <date value="2022-02"/>
  <publisher value="NUM CODEX+ CELIDA"/>
  <description value="In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered."/>
  <goal id="aPTT-goal">
    <category>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="410394004"/>
        <display value="Lab findings surveillance (regime/therapy)"/>
      </coding>
    </category>
    <description>
      <text value="aPTT value should be &gt; 50 sec."/>
    </description>
    <target>
      <measure>
        <coding>
          <system value="http://loinc.org"/>
          <code value="3173-2"/>
          <display value="aPTT in Blood by Coagulation assay"/>
        </coding>
      </measure>
      <detailRange>
        <low>
          <value value="50.0000001"/>
          <unit value="sec"/>
          <system value="http://unitsofmeasure.org"/>
          <code value="s"/>
        </low>
      </detailRange>
    </target>
  </goal>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <goalId value="aPTT-goal"/>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-UFH-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-1xd"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-2xd"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-table"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-nadroparin-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-1xd"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-2xd"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-certoparin-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-fondaparinux-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <goalId value="aPTT-goal"/>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-argatroban-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-tinzaparin-administration"/>
  </action>
</PlanDefinition>